You are here

  • Home
  • Archive
  • Volume 11, Issue Suppl 2
  • 222-N Analysis of pathologic features and efficacy outcomes with neoadjuvant nivolumab plus platinum-doublet chemotherapy for resectable non-small cell lung cancer in CheckMate 816

Article metrics

Article menu

Download PDFPDF

Regular Abstracts – Part 2
Biomarkers, Immune Monitoring and Novel Technologies
222-N Analysis of pathologic features and efficacy outcomes with neoadjuvant nivolumab plus platinum-doublet chemotherapy for resectable non-small cell lung cancer in CheckMate 816

 

Online download statistics by month:

Online download statistics by month: October 2023 to July 2025

AbstractFullPdf
Oct 2023400
Nov 202311608
Dec 20233904
Jan 20241401
Feb 20242801
Mar 20241401
Apr 20241000
May 20242402
Jun 20243400
Jul 20243801
Aug 20241000
Sep 20241403
Oct 20241602
Nov 2024802
Dec 2024204
Jan 20252407
Feb 2025702
Mar 2025001
Apr 2025008
May 2025003
Jun 2025004
Jul 2025001
Total402055